[Form 4] PROLOGIS, INC. Insider Trading Activity

Rhea-AI Filing Summary

Prologis director Cristina G. Bita sold 1,000 shares of Prologis common stock on 09/03/2025 at $111 per share under a pre-established 10b5-1 trading plan. After the sale, she beneficially owned 9,829 shares. The Form 4 lists her address as c/o Prologis in San Francisco and indicates the filing was signed by an attorney-in-fact on 09/04/2025. The transaction is reported as a routine sale executed pursuant to a written plan intended to provide the affirmative defense of Rule 10b5-1, rather than an opportunistic or ad hoc trade.

Insights

Securities Analyst

TL;DR: A routine, pre-planned director sale of 1,000 shares under a 10b5-1 plan; limited immediate market impact.

The sale of 1,000 shares at $111 reduces the director's holdings to 9,829 shares, representing a modest personal liquidity event relative to institutional free float. Because the trade was executed under a 10b5-1 plan dated August 1, 2025, it signals pre-commitment and reduces concerns about material non-public information driving the timing. The filing is procedural and contains no disclosures of company operational or financial changes.

Corporate Governance Expert

TL;DR: Insider sale appears compliant and documented; governance controls (10b5-1 plan) were used.

The Form 4 shows the director used a documented 10b5-1 plan, which is a standard governance tool to mitigate insider trading risk. The report was executed by an attorney-in-fact and properly disclosed on Form 4, aligning with Section 16 reporting requirements. There are no indications of unusual or untimely insider activity in the filing itself.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BITA CRISTINA GABRIELA

(Last) (First) (Middle)

C/O PROLOGIS, INC., PIER 1, BAY 1

(Street)

SAN FRANCISCO CA 94111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Prologis, Inc. [ PLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	09/03/2025	09/03/2025	S		1,000	D	$111	9,829	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. THIS TRANSACTION WAS CONDUCTED IN CONNECTION WITH A 10B5-1 PLAN DATED AUGUST 1, 2025.

	/s/ Tammy Colvocoresses Attorney-In-Fact for Cristina G. Bita	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.